165 related articles for article (PubMed ID: 25634263)
1. DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use.
Weissig V
Methods Mol Biol; 2015; 1265():1-11. PubMed ID: 25634263
[TBL] [Abstract][Full Text] [Related]
2. DQAsomes as the Prototype of Mitochondria-Targeted Pharmaceutical Nanocarriers : An Update.
Weissig V; Lozoya M; Yu N; D'Souza GGM
Methods Mol Biol; 2021; 2275():13-25. PubMed ID: 34118029
[TBL] [Abstract][Full Text] [Related]
3. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
Vaidya B; Vyas SP
J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
[TBL] [Abstract][Full Text] [Related]
4. Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation.
Zupančič Š; Kocbek P; Zariwala MG; Renshaw D; Gul MO; Elsaid Z; Taylor KM; Somavarapu S
Mol Pharm; 2014 Jul; 11(7):2334-45. PubMed ID: 24852198
[TBL] [Abstract][Full Text] [Related]
5. DQAsomes: a novel potential drug and gene delivery system made from Dequalinium.
Weissig V; Lasch J; Erdos G; Meyer HW; Rowe TC; Hughes J
Pharm Res; 1998 Feb; 15(2):334-7. PubMed ID: 9523323
[TBL] [Abstract][Full Text] [Related]
6. Dequalinium-based functional nanosomes show increased mitochondria targeting and anticancer effect.
Bae Y; Jung MK; Lee S; Song SJ; Mun JY; Green ES; Han J; Ko KS; Choi JS
Eur J Pharm Biopharm; 2018 Mar; 124():104-115. PubMed ID: 29305141
[TBL] [Abstract][Full Text] [Related]
7. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes.
Weissig V; Lizano C; Torchilin VP
Drug Deliv; 2000; 7(1):1-5. PubMed ID: 10895413
[TBL] [Abstract][Full Text] [Related]
8. Dequalinium-Derived Nanoconstructs: A Promising Vehicle for Mitochondrial Targeting.
Pawar A; Korake S; Gajbhiye KR
Curr Drug Deliv; 2021; 18(8):1056-1063. PubMed ID: 33475059
[TBL] [Abstract][Full Text] [Related]
9. Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel.
D'Souza GG; Cheng SM; Boddapati SV; Horobin RW; Weissig V
J Drug Target; 2008 Aug; 16(7):578-85. PubMed ID: 18686127
[TBL] [Abstract][Full Text] [Related]
10. Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome.
Lyrawati D; Trounson A; Cram D
Pharm Res; 2011 Nov; 28(11):2848-62. PubMed ID: 21833794
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled nanoparticles composed of glycol chitosan-dequalinium for mitochondria-targeted drug delivery.
Mallick S; Song SJ; Bae Y; Choi JS
Int J Biol Macromol; 2019 Jul; 132():451-460. PubMed ID: 30930268
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-specific nanocarriers for improving the proapoptotic activity of small molecules.
Weissig V
Methods Enzymol; 2012; 508():131-55. PubMed ID: 22449924
[TBL] [Abstract][Full Text] [Related]
13. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells.
D'Souza GG; Rammohan R; Cheng SM; Torchilin VP; Weissig V
J Control Release; 2003 Sep; 92(1-2):189-97. PubMed ID: 14499196
[TBL] [Abstract][Full Text] [Related]
14. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial leader sequence--plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria.
D'Souza GG; Boddapati SV; Weissig V
Mitochondrion; 2005 Oct; 5(5):352-8. PubMed ID: 16154389
[TBL] [Abstract][Full Text] [Related]
16. A thermoresponsive nanocarrier for mitochondria-targeted drug delivery.
Wang D; Huang H; Zhou M; Lu H; Chen J; Chang YT; Gao J; Chai Z; Hu Y
Chem Commun (Camb); 2019 Apr; 55(28):4051-4054. PubMed ID: 30870553
[TBL] [Abstract][Full Text] [Related]
17. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
18. Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy.
Weissig V; Torchilin VP
Curr Pharm Biotechnol; 2000 Dec; 1(4):325-46. PubMed ID: 11467330
[TBL] [Abstract][Full Text] [Related]
19. Intracellular delivery of nanoparticles with CPPs.
Sawant R; Torchilin V
Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
[TBL] [Abstract][Full Text] [Related]
20. DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria.
Weissig V; D'Souza GG; Torchilin VP
J Control Release; 2001 Aug; 75(3):401-8. PubMed ID: 11489326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
